NCT06346457 - Breast Cancer & Antiestrogenic Therapy & Brain | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

April 1, 2026

Conditions

Breast Cancer FemaleHealthy FemaleMenopauseAnti-estrogenic Therapy

Interventions

DRUG

Tamoxifen

Tamoxifen is 20 mg once daily for two to three weeks.

DRUG

Letrozole

Letrozole (Aromatase inhibitor) is 2,5 mg once daily for two to three weeks.

DRUG

Letrozole + GnRH

When they take Letrozole + GnRh, the GnRh is an injection once a month.

Trial Locations (1)

University of Tuebingen; Department of Psychiatry & Psychotherapy Tuebingen, Tübingen